前立腺癌腫瘍マーカーとしての前立腺特異抗原の臨床的意義 - 三者同時測定をおこなつた新鮮前立腺癌113例によるγ-semlnoProtelnおよび前立腺性酸性フォスファターゼとの比較検討 -

Research Japanese OPEN
荒井, 陽一; 吉貴, 達寛; 岡田, 謙一郎; 吉田, 修; 山本, 憲男; 酒徳, 治三郎; 杉村, 芳樹; 川村, 寿一;
(1989)
  • Publisher: 泌尿器科紀要刊行会
  • Journal: 泌尿器科紀要,volume 35,issue 9,pages1,519-1,528 (issn: 0018-1994)
  • Publisher copyright policies & self-archiving
  • Subject: Prostatic specific antigen | r-seminoprotein | Prostatic acid phosphatase | Tumor marker | Prostatic cancer

Serum prostatic specific antigen (PA), gamma-seminoprotein (gamma-Sm) and prostatic acid phosphatase (PAP) levels were measured in 113 untreated patients with prostatic cancer and in 137 patients with benign prostatic hypertrophy (BPH). We used a PA-TESTWAKO enzyme immu... View more
Share - Bookmark

  • Download from
    JAIRO via JAIRO (Research, 1989)
  • Cite this publication